Abvc Biopharma (ABVC) Prepaid Assets (2010 - 2026)

Abvc Biopharma (ABVC) has reported Prepaid Assets for 13 consecutive years, with $151559.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Prepaid Assets fell 22.28% year-over-year to $151559.0; the trailing twelve-month figure through Jun 2026 stood at $151559.0 (down 22.28% YoY), and the FY2025 full-year result was $346616.0, up 260.26% from the prior year.
• Prepaid Assets retreated to $151559.0 in Q2 2026 per ABVC's latest filing, from $250017.0 in the prior quarter.
• Across five years, Prepaid Assets topped out at $1.3 million in Q2 2022 and bottomed at $96213.0 in Q4 2024.
• Historically, Prepaid Assets has averaged $300582.8 across 5 years, with a median of $207322.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Prepaid Assets sank 88.63% in 2023, then soared 291.49% in 2025.
• Over 5 years, Prepaid Assets stood at $150235.0 in 2022, then tumbled by 32.74% to $101051.0 in 2023, then retreated by 4.79% to $96213.0 in 2024, then jumped by 260.26% to $346616.0 in 2025, then tumbled by 56.27% to $151559.0 in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $151559.0, $250017.0, and $346616.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.